Advisors Management Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.85M | Sell |
44,419
-5,120
| -10% | -$490K | 0.7% | 38 |
|
|
2025
Q4 | $4.76M | Sell |
49,539
-3,010
| -6% | -$292K | 0.87% | 34 |
|
|
2025
Q3 | $5M | Buy |
52,549
+704
| +1% | +$64.7K | 0.88% | 36 |
|
|
2025
Q2 | $4.52M | Sell |
51,845
-1,400
| -3% | -$119K | 0.85% | 35 |
|
|
2025
Q1 | $4.79M | Buy |
53,245
+2,470
| +5% | +$221K | 1.04% | 28 |
|
|
2024
Q4 | $4.06M | Buy |
50,775
+5,942
| +13% | +$514K | 0.96% | 34 |
|
|
2024
Q3 | $4.04M | Buy |
44,833
+1,041
| +2% | +$87.6K | 0.95% | 36 |
|
|
2024
Q2 | $3.45M | Buy |
43,792
+14,792
| +51% | +$1.21M | 0.86% | 38 |
|
|
2024
Q1 | $2.53M | Buy |
29,000
+1,043
| +4% | +$89K | 0.63% | 53 |
|
|
2023
Q4 | $2.3M | Buy |
27,957
+1,672
| +6% | +$127K | 0.63% | 53 |
|
|
2023
Q3 | $2.06M | Buy |
26,285
+751
| +3% | +$62.9K | 0.62% | 54 |
|
|
2023
Q2 | $2.25M | Buy |
25,534
+1,870
| +8% | +$161K | 0.67% | 50 |
|
|
2023
Q1 | $1.91M | Buy |
23,664
+19,440
| +460% | +$1.58M | 0.61% | 51 |
|
|
2022
Q4 | $328K | Buy |
4,224
+756
| +22% | +$61.3K | 0.12% | 96 |
|
|
2022
Q3 | $280K | Sell |
3,468
-191
| -5% | -$17.2K | 0.11% | 103 |
|
|
2022
Q2 | $328K | Buy |
3,659
+49
| +1% | +$4.96K | 0.12% | 100 |
|
|
2022
Q1 | $401K | Buy |
3,610
+229
| +7% | +$24.2K | 0.14% | 88 |
|
|
2021
Q4 | $350K | Hold |
3,381
| – | – | 0.1% | 92 |
|
|
2021
Q3 | $424K | Sell |
3,381
-100
| -3% | -$12.9K | 0.13% | 86 |
|
|
2021
Q2 | $432K | Buy |
3,481
+296
| +9% | +$37.2K | 0.13% | 88 |
|
|
2021
Q1 | $376K | Buy |
3,185
+354
| +13% | +$41.5K | 0.12% | 90 |
|
|
2020
Q4 | $332K | Buy |
2,831
+62
| +2% | +$6.83K | 0.14% | 77 |
|
|
2020
Q3 | $288K | Buy |
2,769
+19
| +0.7% | +$1.91K | 0.12% | 78 |
|
|
2020
Q2 | $252K | Buy |
2,750
+81
| +3% | +$7.77K | 0.11% | 81 |
|
|
2020
Q1 | $241K | Buy |
2,669
+265
| +11% | +$28.2K | 0.12% | 78 |
|
|
2019
Q4 | $273K | Hold |
2,404
| – | – | 0.11% | 76 |
|
|
2019
Q3 | $261K | Hold |
2,404
| – | – | 0.11% | 77 |
|
|
2019
Q2 | $234K | Hold |
2,404
| – | – | 0.1% | 82 |
|
|
2019
Q1 | $219K | Hold |
2,404
| – | – | 0.1% | 84 |
|
|
2018
Q4 | $219K | Hold |
2,404
| – | – | 0.12% | 75 |
|
|
2018
Q3 | $236K | Hold |
2,404
| – | – | 0.11% | 81 |
|
|
2018
Q2 | $206K | Buy |
+2,404
| New | +$201K | 0.1% | 82 |
|
|
2017
Q3 | – | Sell |
-2,406
| Closed | -$214K | – | 79 |
|
|
2017
Q2 | $214K | Buy |
+2,406
| New | +$203K | 0.12% | 73 |
|
Other funds holding MDT
VCM
VPM
Advisors Management Group's MDT Position: Q1 2026 in Review
Advisors Management Group reduced its Medtronic (MDT) stake by 10% in Q1 2026, selling an estimated $490K and leaving 44,419 shares worth $3.85M. The position accounts for 0.7% of the portfolio, ranked #38.
Advisors Management Group first reported a position in MDT in Q2 2017 and has held it in 33 quarters since. The position peaked at $5M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Advisors Management Group held 44,419 shares of Medtronic worth $3.85M as of Q1 2026.
- Advisors Management Group sold 5,120 Medtronic shares in Q1 2026, an estimated $490K.
- Medtronic made up 0.7% of Advisors Management Group's portfolio in Q1 2026, its #38 holding.
- Advisors Management Group first reported a position in Medtronic in Q2 2017 and has held it in 33 quarters since.
- Advisors Management Group's Medtronic position peaked at $5M in Q3 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Advisors Management Group's 13F filing for Q1 2026, filed 1 May 2026.